Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quark Venture
Vancouver, British Columbia, Canadaquarkventure.com ↗
- Ownership
- Private
- Employees
- ~3
- Development stage
- Other
01
Overview
Quark Venture does not develop drugs but invests in innovative biotechnology and health sciences companies globally. Its investments span early-stage to late-stage rounds across diverse therapeutic areas including anti-infectives, oncology radiopharmaceuticals, medical isotopes production systems, and immunotherapies. Portfolio highlights include Microbion Corporation’s pravibismane for antibiotic resistance and Alpha‑9 Theranostics’ targeted radiopharmaceuticals for cancer.
Recent investments include Lyndra Therapeutics ($20.35M Series D in June 2023) and Alpha‑9 Oncology ($75M Series B in December 2022).
The firm co-manages a $500 million global health sciences venture fund with GF Securities Company Limited targeting breakthrough drug development platforms as well as medical devices and digital health innovations.
Key people include CEO Karimah Es Sabar and Chairman Jesson Chen.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Small moleculeRadiopharmaceuticalCell therapyMedical device
- Industry
- Investors
02
Partnerships
GF Securities Company Limited (co-manager of $500M global fund)BVF PartnersFrazier Healthcare PartnersLongitude Capital
Beyond the preview
Go deeper on Quark Venture.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Quark Venture.